Tirzepatide, a dual GLP-1 and GIP receptor agonist available through PlexusDx at $289/mo month-to-month, or from $249/mo on the 6-month plan, offers additional appetite suppression through the GIP pathway
Retrieved from Kline, C
US 8598118, Harding JW, Wright JW, Benoist CC, Kawas LH, Wayman GA, "Hepatocyte growth factor mimics as therapeutic agents", issued 3 December 2013 "Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs"
This therapy is often sought out by individuals dealing with chronic inflammation, slow recovery from injuries or surgery, and persistent joint pain
(2023) 67:e2200476
Prim Care Companion CNS Disord 2025;27(4):25cr03935 Submitted: February 7, 2025